Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» December 2011
December 2011
Roche and Pfizer launch pharma's first official Google+ pages
Roche and Pfizer launch pharma's first official Google+ pages
PM Live
Roche
Pfizer
social media
Google+
FDA Extends Taliglucerase Alfa PDUFA Date to May 1, 2012
FDA Extends Taliglucerase Alfa PDUFA Date to May 1, 2012
Yahoo
FDA
taliglucerase alfa
Protalix BioTherapeutics
Gaucher disease
Genmab says rivals appeal U.S. ruling in patent suit
Genmab says rivals appeal U.S. ruling in patent suit
Reuters
patents
Genmab
Biogen Idec
Genentech
GSK
Arzerra
False Claims Probe Did Not Stop Off-Label Marketing
False Claims Probe Did Not Stop Off-Label Marketing
Pharmalot
off-label
False Claims Act
Pfizer
Warner-Lambert
Neurontin
GSK's new R&D culture forces research chiefs to hustle for support
GSK's new R&D culture forces research chiefs to hustle for support
Fierce Biotech
GSK
R&D
Idenix Pharmaceuticals: Go Short Or Bet Long With The Insiders?
Idenix Pharmaceuticals: Go Short Or Bet Long With The Insiders?
Seeking Alpha
Idenix
Optimer's DIFICID provides economic value in the treatment of CDAD
Optimer's DIFICID provides economic value in the treatment of CDAD
Yahoo/Fly on the Wall
Dificid
Optimer
Clostridium Difficile
Takeda unveils plans for global vaccine business
Takeda unveils plans for global vaccine business
Pharma Times, UK
vaccines
Takeda
Samsung, Biogen Idec Agree to Set Up $300 Million Venture
Samsung, Biogen Idec Agree to Set Up $300 Million Venture
Bloomberg
Biogen Idec
Samsung
South Korea
Ranbaxy launches generic Caduet in U.S
Ranbaxy launches generic Caduet in U.S
Yahoo/Reuters
Caduet
Pfizer
Ranbaxy
generics
Pages
« first
‹ previous
…
32
33
34
35
36
37
38
39
40
…
next ›
last »